Ausgabe 3/2022
Inhalt (16 Artikel)
Risk factors for gastric cancer in Japan in the 2010s: a large, long-term observational study
Yu Takahashi, Nobutake Yamamichi, Dai Kubota, Takeshi Shimamoto, Sayaka Nagao, Nobuyuki Sakuma, Yoshiki Sakaguchi, Seiichi Yakabi, Yosuke Tsuji, Ryoichi Wada, Toru Mitsushima, Masao Ichinose, Mitsuhiro Fujishiro
Gastric cancer exosomes contribute to the field cancerization of gastric epithelial cells surrounding gastric cancer
Jung Hwan Yoon, Byung Joon Choi, Suk Woo Nam, Won Sang Park
CAF promotes chemoresistance through NRP2 in gastric cancer
Yanpeng Yang, Yongchen Ma, Shen Yan, Pengyuan Wang, Jianwen Hu, Shanwen Chen, Jing Zhu, Jingui Wang, Guowei Chen, Yucun Liu
Crosstalk between cancer-associated fibroblasts and immune cells in peritoneal metastasis: inhibition in the migration of M2 macrophages and mast cells by Tranilast
Yusuke Nakamura, Jun Kinoshita, Takahisa Yamaguchi, Tatsuya Aoki, Hiroto Saito, Toshihide Hamabe-Horiike, Shinichi Harada, Sachiyo Nomura, Noriyuki Inaki, Sachio Fushida
LRG1 mediated by ATF3 promotes growth and angiogenesis of gastric cancer by regulating the SRC/STAT3/VEGFA pathway
Lingnan He, Anqi Feng, Hui Guo, Haohao Huang, Qingchun Deng, Ende Zhao, Ming Yang
Intracellular MUC20 variant 2 maintains mitochondrial calcium homeostasis and enhances drug resistance in gastric cancer
Lingfeng Fu, Atsuko Yonemura, Noriko Yasuda-Yoshihara, Terumasa Umemoto, Jun Zhang, Tadahito Yasuda, Tomoyuki Uchihara, Takahiko Akiyama, Fumimasa Kitamura, Kohei Yamashita, Yuya Okamoto, Luke Bu, Feng Wei, Xichen Hu, Yang Liu, Jaffer A. Ajani, Patrick Tan, Hideo Baba, Takatsugu Ishimoto
Lysosomal-associated membrane protein family member 5 promotes the metastatic potential of gastric cancer cells
Shinichi Umeda, Mitsuro Kanda, Dai Shimizu, Shunsuke Nakamura, Koichi Sawaki, Yoshikuni Inokawa, Norifumi Hattori, Masamichi Hayashi, Chie Tanaka, Goro Nakayama, Yasuhiro Kodera
rs2671655 single nucleotide polymorphism modulates the risk for gastric cancer in Helicobacter pylori–infected individuals: a genome-wide association study in the Korean population
Cheol Min Shin, Kyungtaek Park, Nayoung Kim, Sungho Won, Jung Hun Ohn, Sejoon Lee, Ji Hyun Park, Seung Joo Kang, Joo Sung Kim, Dong Ho Lee
Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS)
Kohei Shitara, Toshihiko Doi, Hisashi Hosaka, Peter Thuss-Patience, Armando Santoro, Federico Longo, Ozgur Ozyilkan, Irfan Cicin, David Park, Aziz Zaanan, Carles Pericay, Mustafa Özgüroğlu, Maria Alsina, Lukas Makris, Karim A. Benhadji, David H. Ilson
Broad spectrum of regorafenib activity on mutant KIT and absence of clonal selection in gastrointestinal stromal tumor (GIST): correlative analysis from the GRID trial
Michael Jeffers, Christian Kappeler, Iris Kuss, Georg Beckmann, Daniel H. Mehnert, Johannes Fredebohm, Michael Teufel
Ramucirumab plus paclitaxel as a second-line treatment in HER2-positive gastric cancer: subgroup analysis of a nationwide, real-world study in Korea (KCSG-ST19-16)
Bum Jun Kim, Hee-Jung Jee, Sun Young Rha, Hye Sook Han, Min-Hee Ryu, Se Hoon Park, Jong Gwang Kim, Woo Kyun Bae, Keun-Wook Lee, Do-Youn Oh, Ji-Hye Byun, Dong Sook Kim, Young Ju Suh, Hyonggin An, Dae Young Zang
A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
Hirotaka Hasegawa, Kohei Shitara, Shuji Takiguchi, Noriaki Takiguchi, Seiji Ito, Mitsugu Kochi, Hidehito Horinouchi, Takahiro Kinoshita, Takaki Yoshikawa, Kei Muro, Hiroyoshi Nishikawa, Hideaki Suna, Yasuhiro Kodera
Development of the PERI-Gastric (PEritoneal Recurrence Index) and PERI-Gram (Peritoneal Recurrence Index NomoGRAM) for predicting the risk of metachronous peritoneal carcinomatosis after gastrectomy with curative intent for gastric cancer
Annamaria Agnes, Alberto Biondi, Roberto Persiani, Antonio Laurino, Rossella Reddavid, Maurizio De Giuli, Federico Sicoli, Ferdinando Cananzi, Stefano De Pascale, Uberto Fumagalli, Federica Galli, Stefano Rausei, Laura Lorenzon, Domenico D’Ugo
Response to neoadjuvant chemotherapy and survival in molecular subtypes of resectable gastric cancer: a post hoc analysis of the D1/D2 and CRITICS trials
Hedde D. Biesma, Tanya T. D. Soeratram, Karolina Sikorska, Irene A. Caspers, Hendrik F. van Essen, Jacqueline M. P. Egthuijsen, Aart Mookhoek, Hanneke W. M. van Laarhoven, Mark I. van Berge Henegouwen, Marianne Nordsmark, Donald L. van der Peet, Fabienne A. R. M. Warmerdam, Maud M. Geenen, Olaf J. L. Loosveld, Johanneke E. A. Portielje, Maartje Los, Daniëlle A. M. Heideman, Elma Meershoek-Klein Kranenbarg, Henk H. Hartgrink, Johanna van Sandick, Marcel Verheij, Cornelis J. H. van de Velde, Annemieke Cats, Bauke Ylstra, Nicole C. T. van Grieken
Aspirin use in relation to long-term survival after gastrectomy for gastric adenocarcinoma
Dag Holmberg, Joonas H. Kauppila, Fredrik Mattsson, Johannes Asplund, Wilhelm Leijonmarck, Shao-Hua Xie, Jesper Lagergren
A rare gastric lesion: diminutive, well-differentiated, Grade 3, type 3 gastric neuroendocrine tumor with extremely high ki-67 index removed en bloc under endoscopy
Chunpeng Zhu, Hiroshi Kawachi, Xinliang Lu